FBHTX | RAHTX | FBHTX / RAHTX | |
Total Expense Ratio | 0.45 | 1.46 | 31% |
Annual Report Gross Expense Ratio | 0.45 | 1.46 | 31% |
Fund Existence | 11 years | 18 years | - |
Gain YTD | 11.301 | 10.753 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 41.9B | 41.9B | 100% |
Annual Yield % from dividends | 1.26 | 0.41 | 304% |
Returns for 1 year | 13.58 | 12.40 | 109% |
Returns for 3 years | 42.17 | 39.03 | 108% |
Returns for 5 years | 48.44 | 42.92 | 113% |
Returns for 10 years | 82.97 | 75.24 | 110% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SIXS | 47.87 | 0.66 | +1.40% |
ETC 6 Meridian Small Cap Equity ETF | |||
TILT | 227.98 | 1.62 | +0.72% |
FlexShares Mstar US Mkt Factors Tilt ETF | |||
TWOX | 25.46 | 0.14 | +0.55% |
iShares Large Cp Accelerated Outcome ETF | |||
NCV | 14.20 | 0.06 | +0.42% |
Virtus Convertible & Income Fund | |||
FTXH | 26.31 | N/A | +0.01% |
First Trust Nasdaq Pharmaceuticals ETF |